These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 14089154)

  • 1. [ON THE PROBLEM OF THE RECURRENCE OF MEASLES IN CHILDREN].
    KAZANSKII IV; USPENSKAIA MD
    Pediatriia; 1963 Aug; 42():51-5. PubMed ID: 14089154
    [No Abstract]   [Full Text] [Related]  

  • 2. CONTROLLED TRIAL OF LIVE MEASLES VACCINE. EFFECTS OF AGE, HISTORY OF MEASLES IN SIBLINGS, PREVACCINE ANTIBODY, AND HUMAN GAMMA-GLOBULIN ON SYMPTOMATIC AND IMMUNE RESPONSES.
    MARTIN CM; MANFREDONIA SJ; WEBB NC; MARKHAM FS; RUEGSEGGER JM
    Am J Dis Child; 1963 Sep; 106():267-79. PubMed ID: 14057606
    [No Abstract]   [Full Text] [Related]  

  • 3. MEASLES VACCINE FIELD TRIALS IN ALASKA. I. KILLED VACCINE FOLLOWED BY LIVE ATTENUATED VACCINE AND GAMMA-GLOBULIN WITH LIVE ATTENUATED VACCINE.
    BRODY JA; MCALISTER R; EMANUEL I; ALEXANDER ER
    JAMA; 1964 Aug; 189():339-42. PubMed ID: 14160504
    [No Abstract]   [Full Text] [Related]  

  • 4. Measles immunity: reimmunization of children who previously received live measles vaccine and gamma globulin.
    Arbeter AM; Arthur JH; Blakeman GJ; McIntosh K
    J Pediatr; 1972 Oct; 81(4):737-41. PubMed ID: 4116365
    [No Abstract]   [Full Text] [Related]  

  • 5. GLOBULIN-MODIFIED VACCINATION WITH LIVE ATTENUATED MEASLES VIRUS, SUGIYAMA, ADAPTED TO BOVINE RENAL CELLS.
    MINAMITANI M; NAKAMURA K; SHINOZAKI T; TAKAHASHI T; FUJII R; SABURI Y; MATUMOTO M
    Jpn J Exp Med; 1964 Apr; 34():85-8. PubMed ID: 14171677
    [No Abstract]   [Full Text] [Related]  

  • 6. SUPPRESSION OF MEASLES 19S ANTIBODY FORMATION AS EVIDENCE OF IMMUNITY. PRIMARY IMMUNE RESPONSE MASKED BY MATERIAL ANTIBODY.
    SCHLUEDERBERG A; KARELITZ S
    JAMA; 1965 Mar; 191():1064-6. PubMed ID: 14267895
    [No Abstract]   [Full Text] [Related]  

  • 7. MEASLES IMMUNIZATION INCORPORATED IN THE ROUTINE SCHEDULE FOR INFANTS: EFFICACY OF A COMBINED INACTIVATED-LIVE VACCINATION REGIMEN.
    KRUGMAN S; STONE S; HU R; FRIEDMAN H
    Pediatrics; 1964 Dec; 34():795-7. PubMed ID: 14243467
    [No Abstract]   [Full Text] [Related]  

  • 8. Measles immune globulin. Proposed standard dose given with liver attenuated measles virus vaccine.
    Warren RJ; Nader PR; Levine RH
    JAMA; 1968 Jan; 203(3):186-8. PubMed ID: 4169348
    [No Abstract]   [Full Text] [Related]  

  • 9. [Studies on immunity to measles. II. Prophylactic and serological studies on the use of live and attenuated measles-virus vaccine].
    Egami T
    Kumamoto Igakkai Zasshi; 1966 May; 40(5):539-62. PubMed ID: 4164172
    [No Abstract]   [Full Text] [Related]  

  • 10. MEASLES VACCINATION IN ADULTS WITH AND WITHOUT COMPLICATING CONDITIONS.
    GUDNADOTTIR M; BLACK FL
    Arch Gesamte Virusforsch; 1965; 16():521-3. PubMed ID: 14322927
    [No Abstract]   [Full Text] [Related]  

  • 11. Measles vaccination in Iceland: three-year follow-up of antibody titres in adults and children.
    Black FL; Gudnadóttir M
    Bull World Health Organ; 1966; 35(6):955-7. PubMed ID: 4165239
    [No Abstract]   [Full Text] [Related]  

  • 12. [Results of the inoculation test of measles vaccine. 1. The result of measles-attenuated live virus vaccine].
    Santo K
    Nihon Shonika Gakkai Zasshi; 1967 Mar; 71(3):332-43. PubMed ID: 4168846
    [No Abstract]   [Full Text] [Related]  

  • 13. IMMUNIZATION WITH LIVE MEASLES VACCINE. REPORT OF A FIELD TRIAL IN HAWAII.
    ROTH A
    Hawaii Med J; 1965; 24():374-5. PubMed ID: 14327633
    [No Abstract]   [Full Text] [Related]  

  • 14. THE EFFECT OF MEASLES, GAMMA GLOBULIN MODIFIED MEASLES, AND ATTENUATED MEASLES VACCINE ON THE COURSE OF TREATED TUBERCULOSIS IN CHILDREN.
    STARR S; BERKOVICH S
    Pediatrics; 1965 Jan; 35():97-102. PubMed ID: 14223232
    [No Abstract]   [Full Text] [Related]  

  • 15. [REPORT OF TEST OF ANTI-MEASLES VACCINATION WITH ATTENUATED LIVING VIRUS].
    CARBONELL JUANICO M; FARRE SOSTRES I; CARDELUS GASSIOT JI; CARBONELL ESTRANY M
    Rev Esp Pediatr; 1963; 19():563-79. PubMed ID: 14094748
    [No Abstract]   [Full Text] [Related]  

  • 16. [SIGNIFICANCE OF MEASLES. II].
    WESSELIUS-DECASPARIS A; VAN HERCK ; SOETERS GC; TEGELAERS WH
    Maandschr Kindergeneeskd; 1964 Mar; 32():85-100. PubMed ID: 14152671
    [No Abstract]   [Full Text] [Related]  

  • 17. VACCINATION OF INFANTS WITH LIVING ATTENUATED MEASLES VACCINE (EDMONSTON STRAIN) WITH AND WITHOUT GAMMA-GLOBULIN.
    BENSON PF; BUTLER NR; GOFFE AP; KNIGHT GJ; LAURENCE GD; MILLER CL; POLLOCK TM
    Br Med J; 1964 Oct; 2(5413):851-3. PubMed ID: 14185636
    [No Abstract]   [Full Text] [Related]  

  • 18. A CONTROLLED TRIAL OF LIVER-VIRUS VACCINE AGAINST MEASLES IN CHILE.
    RISTORI C; BOCCARDO H; MIRANDA M; BORGONO M
    Bull World Health Organ; 1964; 30(6):763-8. PubMed ID: 14215183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measles in children previously vaccinated against measles.
    Lerman SJ; Gold E
    JAMA; 1971 May; 216(8):1311-4. PubMed ID: 4102807
    [No Abstract]   [Full Text] [Related]  

  • 20. MEASLES VACCINATION.
    BUDAI J; FARKAS E; NYERGES G; CSAPO J
    Acta Paediatr Acad Sci Hung; 1964; 5():435-41. PubMed ID: 14236548
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.